Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy

Cancer Research

Volumn 65, Issue 23, 2005, Pages 10642-10645

  Caprioli, Richard M ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROTEIN;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE MARKER; GLIOMA; HISTOPATHOLOGY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEOMICS; REVIEW; TUMOR BIOPSY;

HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; PROTEOMICS;

EID: 28344438939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3581     Document Type: Review

References (12)

1. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;9:362:433-9.
2. Reyzer ML, Caldwell RL, Dugger TC, et al. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 2004;64:9093-100.
3. Eastham JA, Riedel E, Scardino PT, et al. Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. JAMA 2003;289:2695-700.
4. Shin BK, Wang H, Hanash S. Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer. J Mammary Gland Biol Neoplasia 2005;7:407-13.
5. Steel LF, Shumpert D, Trotter M, et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 2003;3:601-9.
6. Chaurand P, Schwartz SA, Caprioli RM. Profiling and imaging proteins in tissue sections by MS. Anal Chem 2004;76:87-93A.
7. Chaurand P, Sanders ME, Jensen RA, Caprioti RM. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 2004;165:1057-68.
8. Washburn MP, Wolters D, Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19:242-7.
9. Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption mass spectrometry. Cancer Res 2005;65:7674-81.
10. Schwartz SA. Proteomic-based classification of human brain tumors by mass spectrometry. Ph D. Dissertation; Vanderbilt University, 2004.
11. Aldape K, Simmons ML, Davis RL. Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 2000; 88:2342-9.
12. Castillo MS, Davis FG, Surawicz T. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems. Neuroepidemiology 2004;23: 85-93.